EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A Spatiotemporal Model of CXCL10 as a Master Regulator of Immune Evasion and Metastasis in Osteosarcoma

Benjamin B Gyau iD, Tsz-Kwong Man iD

International Journal of Molecular Sciences · 27.12.2025 · 27 (1) · 319

DOI: 10.3390/ijms27010319 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.12.2025. Verfasst von Benjamin B Gyau und 1 weiteren Autor:innen. Beteiligte Einrichtung: Section of Hematology and Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Osteosarcoma, Chemokine CXCL10, Bone Neoplasms, Tumor Escape. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 211 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Prevention and Research Institute of Texas.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The C-X-C motif chemokine ligand 10 (CXCL10) is implicated in the progression of osteosarcoma (OS), the most aggressive pediatric bone malignancy. However, its role often presents a profound clinical paradox: although high circulating levels are strongly linked to poor prognosis, its canonical function is to recruit anti-tumor immune cells. This review unravels these contrasting roles by proposing a novel spatiotemporal model. We argue that in the early stages, immune-evading OS cells initiate the formation of a pre-metastatic niche (PMN) in the lungs, creating a localized inflammatory environment that becomes the primary source of elevated circulating CXCL10. As the disease progresses, elevated systemic levels of CXCL10 overwhelm the localized chemokine gradient at the primary tumor site, creating a potent immune decoy that diverts anti-tumor CXCR3+ T cells away from the tumor. The resulting immune desertification permits unchecked tumor growth and an increased metastatic burden. We also discuss the therapeutic implications of this model, proposing that disrupting the chemokine axis offers a roadmap for developing rational, stage-specific therapies to effectively combat metastatic OS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaChemokine CXCL10Bone NeoplasmsTumor EscapeHumansAnimalsNeoplasm MetastasisTumor MicroenvironmentReceptors, CXCR3Signal Transduction

Stichwörter der Autor:innen

CXCL10CXCR3chemokine signalingimmune cell traffickingimmune evasioninflammationmetastasisosteosarcomapre-metastatic nichetumor microenvironment

Substanzen

Chemokine CXCL10Receptors, CXCR3CXCL10 protein, human

Autor:innen und Institutionen

  • Section of Hematology and Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.
  • Texas Children's Cancer and Hematology Center, Houston, TX 77030, USA.
  • Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.

ORCID-Profile: Benjamin B Gyau, Tsz-Kwong Man

Förderung

  • Cancer Prevention and Research Institute of Texas

Zitieren

APA

Gyau, B. B., & Man, T. K. (2025). A Spatiotemporal Model of CXCL10 as a Master Regulator of Immune Evasion and Metastasis in Osteosarcoma. International Journal of Molecular Sciences, 27(1), 319. https://doi.org/10.3390/ijms27010319

Vancouver

Gyau BB, Man TK. A Spatiotemporal Model of CXCL10 as a Master Regulator of Immune Evasion and Metastasis in Osteosarcoma. International Journal of Molecular Sciences. 2025;27(1):319. doi:10.3390/ijms27010319

BibTeX
@article{Gyau2025,
  author = {Gyau, Benjamin B and Man, Tsz-Kwong},
  title = {A Spatiotemporal Model of CXCL10 as a Master Regulator of Immune Evasion and Metastasis in Osteosarcoma},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {27},
  number = {1},
  pages = {319},
  doi = {10.3390/ijms27010319}
}
Kostenlos starten →